Biber, Josef
Jabri, Yassin
Glänzer, Sarah
Dort, Aaron
Hoffelner, Patricia
Schmidt, Christoph Q.
Bludau, Oliver
Pauly, Diana
Grosche, Antje
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (399392938 –PA1844/3-1, 399392938 – GR4403/5-1)
Philipps-Universität Marburg
Article History
Received: 11 October 2023
Accepted: 14 February 2024
First Online: 22 February 2024
Declarations
:
: All experiments were performed in accordance with European Community Council Directive 86/609/EEC and were approved by local authorities (ROB-55.2-2532.Vet_02_19_151).
: Not applicable.
: DP owns or owned stock in Apellis Pharmaceuticals, Iveric Bio (Astellas) and Omeros. The remaining authors of this paper declare that they have no competing interests.